Capital Research Global Investors 13D and 13G filings for Integra LifeSciences Holdings Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 12:54 pm Sale |
2024-11-07 | 13G | Integra LifeSciences Holdings Corporation IART |
Capital Research Global Investors | 1,304,615 1.700% |
-2,992,711 (-69.64%) |
Filing |
| 2024-02-09 5:49 pm Purchase |
2024-02-07 | 13G | Integra LifeSciences Holdings Corporation IART |
Capital Research Global Investors | 4,297,326 5.500% |
427,556 (+11.05%) |
Filing |
| 2022-07-08 11:22 am Sale |
2022-07-08 | 13G | Integra LifeSciences Holdings Corporation IART |
Capital Research Global Investors | 3,869,770 4.700% |
-4,349,363 (-52.92%) |
Filing |
| 2022-02-11 12:22 pm Sale |
2022-02-14 | 13G | Integra LifeSciences Holdings Corporation IART |
Capital Research Global Investors | 8,219,133 9.700% |
-18,148 (-0.22%) |
Filing |
| 2021-02-16 3:11 pm Sale |
2021-02-16 | 13G | Integra LifeSciences Holdings Corporation IART |
Capital Research Global Investors | 8,237,281 9.800% |
-883,672 (-9.69%) |
Filing |